Edition:
United Kingdom

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

5.91USD
19 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.91
Open
$5.83
Day's High
$5.91
Day's Low
$5.83
Volume
408
Avg. Vol
2,026
52-wk High
$7.26
52-wk Low
$3.87

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 104.93 37.25
P/E High - Last 5 Yrs. -- 162.20 57.61
P/E Low - Last 5 Yrs. -- 51.16 28.59
Beta -- 1.20 0.96
Price to Sales (TTM) -- 42.66 10.17
Price to Book (MRQ) -- 12.57 4.51
Price to Tangible Book (MRQ) -- 18.45 5.33
Price to Cash Flow (TTM) -- 69.22 25.96
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.63
Dividend Yield - 5 Year Avg -- 0.05 1.34
Dividend 5 Year Growth Rate -- 0.77 6.50
Payout Ratio(TTM) -- 1.46 37.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 59.87 15.39
Sales (TTM) vs TTM 1 Yr. Ago -- 45.94 8.68
Sales - 5 Yr. Growth Rate -- 33.23 10.38
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -8.61 18.74
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 22.03 7.13
Capital Spending - 5 Yr. Growth Rate -- 24.55 7.95

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.74 2.47
Current Ratio (MRQ) -- 3.75 3.43
LT Debt to Equity (MRQ) -- 7.71 14.10
Total Debt to Equity (MRQ) -- 21.10 19.80
Interest Coverage (TTM) -- 35.75 15.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 27.34 50.03
Gross Margin - 5 Yr. Avg. -- 59.67 51.24
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -7.64 16.16
Operating Margin (TTM) -- -107.66 -7.96
Operating Margin - 5 Yr. Avg. -- -24.07 11.42
Pre-Tax Margin (TTM) -- -108.84 -8.43
Pre-Tax Margin - 5 Yr. Avg. -- -29.64 16.18
Net Profit Margin (TTM) -- -114.47 -12.23
Net Profit Margin - 5 Yr. Avg. -- -35.00 11.35
Effective Tax Rate (TTM) -- 17.23 20.14
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.32

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 8,319,575 784,041,417
Net Income/Employee (TTM) -- 1,738,124 91,870,420
Receivable Turnover (TTM) -- 10.98 5.82
Inventory Turnover (TTM) -- 2.42 3.68
Asset Turnover (TTM) -- 0.33 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.34 9.69
Return on Assets - 5 Yr. Avg. -- 6.24 10.67
Return on Investment (TTM) -- 7.73 12.15
Return on Investment - 5 Yr. Avg. -- 8.17 13.58
Return on Equity (TTM) -- 8.25 16.99
Return on Equity - 5 Yr. Avg. -- 9.18 15.11

Performance for BiondVax Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.